MMED – minimed group, inc. (US:NASDAQ)

News

MiniMed to announce financial results for its fourth quarter and full fiscal year 2026
MiniMed Group (MMED) was upgraded by Zacks Research to "hold".
Is It Time To Revisit Minimed Group (MMED) After Recent Share Price Weakness? [Yahoo! Finance]
MiniMed Group (MMED) is now covered by Barclays PLC. They set an "overweight" rating and a $26.00 price target on the stock.
MiniMed initiated with ‘Buy' rating by Bank of America on pipeline-driven growth outlook [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com